| Dr Frank Bly Hatch, DC | |
|
18761 N Reems Rd, Suite 400, Surprise, AZ 85374-8646 | |
| (623) 583-9180 | |
| (623) 583-2871 |
| Full Name | Dr Frank Bly Hatch |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 32 Years |
| Location | 18761 N Reems Rd, Surprise, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235297144 | NPI | - | NPPES |
| AZ0932140 | Other | AZ | BLUE CROSS BLUE SHIELD |
| AZ5592 | Other | AZ | HEALTHNET |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 5057 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| White Tank Medical Pllc | 1759746704 | 3 |
| Hassayampa Health Services Llc | 6406249762 | 2 |
News Archive
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
St. Jude Children's Research Hospital discovery of genetic links to multi-drug resistance gives clinicians new insight into the cause of treatment failure and suggests targets for novel anti-leukemic drugs
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
"Adult women who had their first menstruation at the age of 10 or earlier have significantly lower lung capacity than women who had their first period at 13", Ferenc Macsali, lead author of the study and a researcher at the Haukeland Hospital in Bergen (Norway), tells SINC.
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.
› Verified 1 days ago
| Provider Name | Array Medical Center Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205359171 PECOS PAC ID: 8022382506 Enrollment ID: O20170921002518 |
News Archive
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
St. Jude Children's Research Hospital discovery of genetic links to multi-drug resistance gives clinicians new insight into the cause of treatment failure and suggests targets for novel anti-leukemic drugs
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
"Adult women who had their first menstruation at the age of 10 or earlier have significantly lower lung capacity than women who had their first period at 13", Ferenc Macsali, lead author of the study and a researcher at the Haukeland Hospital in Bergen (Norway), tells SINC.
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.
› Verified 1 days ago
| Provider Name | Array Medical Center Surprise Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1992269658 PECOS PAC ID: 3173863701 Enrollment ID: O20190319001239 |
News Archive
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
St. Jude Children's Research Hospital discovery of genetic links to multi-drug resistance gives clinicians new insight into the cause of treatment failure and suggests targets for novel anti-leukemic drugs
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
"Adult women who had their first menstruation at the age of 10 or earlier have significantly lower lung capacity than women who had their first period at 13", Ferenc Macsali, lead author of the study and a researcher at the Haukeland Hospital in Bergen (Norway), tells SINC.
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.
› Verified 1 days ago
| Provider Name | Hassayampa Health Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770241606 PECOS PAC ID: 6406249762 Enrollment ID: O20220209000466 |
News Archive
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
St. Jude Children's Research Hospital discovery of genetic links to multi-drug resistance gives clinicians new insight into the cause of treatment failure and suggests targets for novel anti-leukemic drugs
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
"Adult women who had their first menstruation at the age of 10 or earlier have significantly lower lung capacity than women who had their first period at 13", Ferenc Macsali, lead author of the study and a researcher at the Haukeland Hospital in Bergen (Norway), tells SINC.
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.
› Verified 1 days ago
| Provider Name | White Tank Medical Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1306549837 PECOS PAC ID: 1759746704 Enrollment ID: O20230427000829 |
News Archive
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
St. Jude Children's Research Hospital discovery of genetic links to multi-drug resistance gives clinicians new insight into the cause of treatment failure and suggests targets for novel anti-leukemic drugs
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
"Adult women who had their first menstruation at the age of 10 or earlier have significantly lower lung capacity than women who had their first period at 13", Ferenc Macsali, lead author of the study and a researcher at the Haukeland Hospital in Bergen (Norway), tells SINC.
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank Bly Hatch, DC 18761 N Reems Rd, Suite 400, Surprise, AZ 85374-8646 Ph: (623) 583-9180 | Dr Frank Bly Hatch, DC 18761 N Reems Rd, Suite 400, Surprise, AZ 85374-8646 Ph: (623) 583-9180 |
News Archive
Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit will present data that suggests low levels of pre-treatment radiation mimicking the doses delivered by CT scans for image guidance pose no risk to the efficacy of radiotherapy in patients with prostate carcinoma and non-small cell lung carcinoma. The findings will be formally announced on Sunday, Oct. 31, during the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting.
St. Jude Children's Research Hospital discovery of genetic links to multi-drug resistance gives clinicians new insight into the cause of treatment failure and suggests targets for novel anti-leukemic drugs
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
"Adult women who had their first menstruation at the age of 10 or earlier have significantly lower lung capacity than women who had their first period at 13", Ferenc Macsali, lead author of the study and a researcher at the Haukeland Hospital in Bergen (Norway), tells SINC.
New research from the University of Michigan Comprehensive Cancer Center finds that the protein HER2 plays a role even in breast cancers that would traditionally be categorized as HER2-negative - and that the drug Herceptin, which targets HER2, may have an even greater role for treating breast cancer and preventing its spread.
› Verified 1 days ago
Jessica Kala Turner Lopez, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 14239 W Bell Rd Ste 108, Surprise, AZ 85374 Phone: 623-248-4283 Fax: 623-440-4255 | |
Innate Family Chiropractic P.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 16168 W Clinton St, Surprise, AZ 85379 Phone: 623-698-7771 | |
Dr. Ronald C. Pike, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 18761 N Reems Rd, Suite 400, Surprise, AZ 85374 Phone: 623-583-9180 Fax: 623-583-2871 | |
Jason Lee Hawkins, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 17014 W Bell Rd Ste 103, Surprise, AZ 85374 Phone: 602-680-5161 | |
Brice Wiltgen, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 15288 W Brookside Ln Ste 139, Surprise, AZ 85374 Phone: 623-544-4444 | |
Dr. Trevor John Heid, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 16944 W Bell Rd, Suite 602, Surprise, AZ 85374 Phone: 623-505-7226 Fax: 623-518-2679 | |
Dr. Charles W. Enouen, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 15508 W Bell Rd, Suite 105, Surprise, AZ 85374 Phone: 623-556-4772 |